GenI-AIRSPACE

 Prostate — Recruiting

GenI-AIRSPACE
The aim of this study is to see how the results of genetic testing affects decision making for people with favourable intermediate risk prostate cancer and whether we can safely use these results to make a stronger recommendation for active surveillance for people who have lower genetic risk scores (or recommend treatment if their risk of their cancer progressing is deemed higher).
If you think this trial might be right for you, please ask your doctor.
If you think this trial might be right for you, please ask your doctor.
Trial Title
Evaluating the effect of genomically informed treatment decision-making on long-term oncological outcomes for individuals diagnosed with intermediate risk prostate cancer undergoing active surveillance(ANZUP 2102)
Cancer Type
Prostate
Trial Status
Recruiting
Protocol Number
ANZUP2102
Co-ordinating centre
Study Chair
Professor Niall Corcoran
Study Objective

The aim of this study is to see how the results of genetic testing affects decision making for people with favourable intermediate risk prostate cancer and whether we can safely use these results to make a stronger recommendation for active surveillance for people who have lower genetic risk scores (or recommend treatment if their risk of their cancer progressing is deemed higher).

Patient Population
People with Intermediate-risk Prostate Cancer
Recruitment Target
Stage 1: 112 participants, Stage 2: 348 participants, Stage 3: 1950 participants
Acknowledgements
This study has been funded by the Victorian State Government through the Victorian Medical Research Acceleration Funding grant.
Collaborators
Detailed Information
ANZCTR
Participating Centres
VIC
Royal Melbourne Hospital

Participating Centres